CARLISLE HEALTHCARE — All Prescriptions & Medications — Page 16
Practice Code: A82016 | CARLISLE, CA1 3UB
Showing results 751-800 of 944
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 23 | 844 | £66 | +53.1% ▲ |
| Tube feed 1 kcal/ml peptide based (0914041) | 23 | 511.5K | £12.3K | +158.8% ▲ |
| 23 | 175 | £360 | +95.1% ▲ | |
| Magnesium glycerophosphate | 22 | 2,760 | £1.1K | +60.1% ▲ |
| Vitamin A | 22 | 644 | £64 | +95.1% ▲ |
| Vitamin B compound | 22 | 1,680 | £49 | -84.2% ▼ |
| Tube feed 0.8 kcal/ml with fibre, higher protein (0914011) | 22 | 574.0K | £9.1K | +79.6% ▲ |
| Tube feed 1.5 kcal/ml (0914021) | 22 | 309.0K | £8.0K | +160.0% ▲ |
| Cyclopentolate hydrochloride | 22 | 110 | £178 | +284.6% ▲ |
| Lidocaine | 22 | 520 | £451 | +91.4% ▲ |
| 22 | 310 | £961 | +7.7% ▲ | |
| Zuclopenthixol hydrochloride | 21 | 5,100 | £391 | -33.4% ▼ |
| Risperidone | 21 | 56 | £4.5K | +37.5% ▲ |
| Selegiline hydrochloride | 21 | 1,277 | £228 | +91.5% ▲ |
| Colistimethate sodium | 21 | 1,592 | £6.4K | +85.7% ▲ |
| Apraclonidine | 21 | 1,309 | £5.9K | +66.7% ▲ |
| Mupirocin | 21 | 84 | £113 | +78.9% ▲ |
| 21 | 235 | £347 | +111.8% ▲ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 20 | 728 | £95 | -42.5% ▼ |
| Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | 20 | 1,120 | £494 | +22.3% ▲ |
| Lacidipine | 20 | 756 | £66 | -83.3% ▼ |
| Nefopam hydrochloride | 20 | 2,526 | £110 | -82.3% ▼ |
| Other phosphate supplement preparations | 20 | 2,720 | £506 | +227.8% ▲ |
| RtS 2.4 kcal/ml milkshake lower volume with fibre (0913021) | 20 | 120.5K | £4.5K | +113.3% ▲ |
| Tafluprost and timolol | 20 | 810 | £392 | +4.2% ▲ |
| Hydrocortisone butyrate | 20 | 2,000 | £101 | +202.1% ▲ |
| 20 | 200 | £574 | +217.0% ▲ | |
| 20 | 1,230 | £4.1K | -10.7% ▼ | |
| 20 | 580 | £1.3K | -2.4% ▼ | |
| Rimegepant | 19 | 226 | £2.9K | +93.7% ▲ |
| Ethosuximide | 19 | 1,682 | £3.6K | +28.8% ▲ |
| Hydrocortisone sodium phosphate | 19 | 49 | £101 | +355.3% ▲ |
| Potassium citrate | 19 | 4,124 | £487 | +123.9% ▲ |
| Mycophenolic sodium | 19 | 1,608 | £1.8K | +94.8% ▲ |
| Triptorelin embonate | 19 | 19 | £7.9K | +90.9% ▲ |
| Gel OTC glucose for diabetic hypo treatment (0913541) | 19 | 2,679 | £251 | +59.2% ▲ |
| Calamine | 19 | 3,900 | £37 | +150.7% ▲ |
| 19 | 340 | £3.1K | +81.8% ▲ | |
| 19 | 19 | £118 | +401.1% ▲ | |
| 19 | 190 | £483 | +61.6% ▲ | |
| 19 | 690 | £202 | +31.8% ▲ | |
| 19 | 1,080 | £364 | +82.6% ▲ | |
| 19 | 830 | £5.5K | +87.0% ▲ | |
| Naftidrofuryl oxalate | 18 | 4,368 | £510 | -44.8% ▼ |
| Daridorexant | 18 | 471 | £628 | +37.7% ▲ |
| Flupentixol hydrochloride | 18 | 481 | £66 | -17.9% ▼ |
| Modafinil | 18 | 1,578 | £108 | -13.7% ▼ |
| Trihexyphenidyl hydrochloride | 18 | 2,800 | £280 | -36.5% ▼ |
| Ivermectin | 18 | 127 | £1.5K | +84.5% ▲ |
| Hydroxycarbamide | 18 | 1,092 | £172 | -37.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.